title: Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.
authors.forename: M Hilmi
authors.initials: MH
authors.lastname: Atay
authors.forename: Duzgun
authors.initials: D
authors.lastname: Ozatli
authors.forename: Engin
authors.initials: E
authors.lastname: Kelkitli
authors.forename: Levent
authors.initials: L
authors.lastname: Yildiz
authors.forename: Mehmet
authors.initials: M
authors.lastname: Turgut
authors.forename: Nil
authors.initials: N
authors.lastname: Guler
authors.forename: Tayfur
authors.initials: T
authors.lastname: Toptas
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism*; D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D060588:LIM Domain Proteins / Q000378:metabolism*; D007938:Leukemia / Q000378:metabolism*; D008221:Lymphoid Tissue / Q000378:metabolism*; D008223:Lymphoma / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D014408:Biomarkers, Tumor; D060588:LIM Domain Proteins; D011518:Proto-Oncogene Proteins